Percutaneous Transluminal Angioplasty Registry

PTA Registry - an Observational Study of Percutaneous Transluminal Angioplasty

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02728479

Enrollment

1000

Registered

2016-04-05

Start date

2014-01-31

Completion date

2030-01-31

Last updated

2020-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Percutaneous Transluminal Angioplasty

Brief summary

Percutaneous transluminal angioplasty (PTA) is a minimally invasive procedure for dilating blood vessels in the treatment of peripheral artery disease. The aim of this registry is to collect prospectively and systematically clinical research data from patients undergoing PTA. This registry is an open-end observational study to assess the characteristics and outcomes in patients with undergoing PTA.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients undergoing PTA

Exclusion criteria

* \< 18 years

Design outcomes

Primary

Measure	Time frame
Patency rate	6 months
Creatinine level	2 Days after PTA

Secondary

Measure	Time frame	Description
Ankle-Brachial Index	6 months and 12 months	Clinical Improvement measured by Ankle-Brachial Index
Mortality	30 days	—
Restenosis rate	12 months	Percentage of patients with restenosis at 12 months
walking distance	6 months and 12 months	Clinical Improvement measured by walking distance
Days of Hospitalization	12 months	Days of Hospitalization at 12 months

Countries

Germany

Contacts

Primary ContactChristian Heiss, MD

christian.heiss@med.uni-duesseldorf.de+49 211 8118800

Backup ContactRabea Wagstaff, BSc., M.A.

rabea.wagstaff@med.uni-duesseldorf.de+49 211 8118800

Outcome results